According to data from the Colombian Association of Sleep Medicine (ACMES), 2,812 cases were registered in the country between 2015 and 2025. Credit: Image generated with ChatGPT AIChina has become the first country in the world to approve oveporexton, a new drug for narcolepsy. China’s National Medical Products Administration (NMPA) authorized the medicine, marketed as Orzeyful, for adults and adolescents aged 16 and older with narcolepsy type 1. According to Pharmaphorum, narcolepsy type 1 represents about 60% to 70% of all diagnosed cases. Oveporexton introduces a different therapeutic strategy by targeting orexin signaling, the biological mechanism affected in narcolepsy type 1.